Meshanni J, Stevenson E, Zhang D, Sun R, Ona N, Reagan E
Nat Commun. 2025; 16(1):1806.
PMID: 39984450
PMC: 11845678.
DOI: 10.1038/s41467-025-56448-y.
Ye R, Wei Y, Li J, Zhong Y, Chen X, Li C
Mol Med. 2025; 31(1):40.
PMID: 39901167
PMC: 11792199.
DOI: 10.1186/s10020-025-01111-x.
Xie R, Tan D, Liu B, Xiao G, Gong F, Zhang Q
MedComm (2020). 2025; 6(2):e70074.
PMID: 39866839
PMC: 11769712.
DOI: 10.1002/mco2.70074.
Cheng S, Li Y, Sun X, Liu Z, Guo L, Wu J
Front Immunol. 2024; 15:1508985.
PMID: 39712019
PMC: 11659153.
DOI: 10.3389/fimmu.2024.1508985.
Hsieh L, Hsieh S, Ping T, Huang Y, Lin S, Chi H
Pharm Biol. 2024; 63(1):1-13.
PMID: 39670672
PMC: 11648134.
DOI: 10.1080/13880209.2024.2433994.
Harmonising cellular conversations: decoding the vital roles of extracellular vesicles in respiratory system intercellular communications.
Jadamba B, Jin Y, Lee H
Eur Respir Rev. 2024; 33(174).
PMID: 39537245
PMC: 11558538.
DOI: 10.1183/16000617.0272-2023.
The therapeutic potential of gelsolin in attenuating cytokine storm, ARDS, and ALI in severe COVID-19.
Zhi J, Zhao K, Liu J, Yang D, Deng X, Xu J
Front Pharmacol. 2024; 15:1447403.
PMID: 39130641
PMC: 11310015.
DOI: 10.3389/fphar.2024.1447403.
The ARDS microenvironment enhances MSC-induced repair via VEGF in experimental acute lung inflammation.
Tunstead C, Volkova E, Dunbar H, Hawthorne I, Bell A, Crowe L
Mol Ther. 2024; 32(10):3422-3432.
PMID: 39108095
PMC: 11489539.
DOI: 10.1016/j.ymthe.2024.08.003.
Targeted delivery of TGF-β mRNA to lung parenchyma using one-component ionizable amphiphilic Janus Dendrimers.
Atochina-Vasserman E, Meshanni J, Stevenson E, Zhang D, Sun R, Ona N
Res Sq. 2024; .
PMID: 39041040
PMC: 11261981.
DOI: 10.21203/rs.3.rs-4656663/v1.
Scutellarein Suppresses the Production of ROS and Inflammatory Mediators of LPS-Activated Bronchial Epithelial Cells and Attenuates Acute Lung Injury in Mice.
Li X, Zhang X, Kang Y, Cai M, Yan J, Zang C
Antioxidants (Basel). 2024; 13(6).
PMID: 38929149
PMC: 11200809.
DOI: 10.3390/antiox13060710.
Macrophage biomimetic nanoparticle-targeted functional extracellular vesicle micro-RNAs revealed via multiomics analysis alleviate sepsis-induced acute lung injury.
Wang G, Ma X, Huang W, Wang S, Lou A, Wang J
J Nanobiotechnology. 2024; 22(1):362.
PMID: 38910259
PMC: 11194988.
DOI: 10.1186/s12951-024-02597-z.
Polyphenols as Therapeutics in Respiratory Diseases: Moving from Preclinical Evidence to Potential Clinical Applications.
Emran T, Eva T, Zehravi M, Islam F, Khan J, Kareemulla S
Int J Biol Sci. 2024; 20(8):3236-3256.
PMID: 38904027
PMC: 11186353.
DOI: 10.7150/ijbs.93875.
Acute Lung Injury and the NLRP3 Inflammasome.
Gu W, Zeng Q, Wang X, Jasem H, Ma L
J Inflamm Res. 2024; 17:3801-3813.
PMID: 38887753
PMC: 11182363.
DOI: 10.2147/JIR.S464838.
ANGPTL2 knockdown induces autophagy to relieve alveolar macrophage pyroptosis by reducing LILRB2-mediated inhibition of TREM2.
Yang F, Chen M, Liu Y, Hu Y, Chen Y, Yu Y
J Cell Mol Med. 2024; 28(10):e18280.
PMID: 38758159
PMC: 11100552.
DOI: 10.1111/jcmm.18280.
Network Pharmacology Analysis of the Therapeutic Potential of Colchicine in Acute Lung Injury.
Sun F, Zhang L, Shen L, Wang C
Int J Clin Pract. 2024; 2024:9940182.
PMID: 38352962
PMC: 10864054.
DOI: 10.1155/2024/9940182.
TIMP-1 and its potential diagnostic and prognostic value in pulmonary diseases.
Almuntashiri S, Alhumaid A, Zhu Y, Han Y, Dutta S, Khilji O
Chin Med J Pulm Crit Care Med. 2024; 1(2):67-76.
PMID: 38343891
PMC: 10857872.
DOI: 10.1016/j.pccm.2023.05.002.
Advantages and disadvantages of treatment of experimental ARDS by M2-polarized RAW 264.7 macrophages.
Kosyreva A, Vishnyakova P, Tsvetkov I, Kiseleva V, Dzhalilova D, Miroshnichenko E
Heliyon. 2023; 9(11):e21880.
PMID: 38027880
PMC: 10658332.
DOI: 10.1016/j.heliyon.2023.e21880.
Circulating Surfactant Protein D: A Biomarker for Acute Lung Injury?.
Elmore A, Almuntashiri A, Wang X, Almuntashiri S, Zhang D
Biomedicines. 2023; 11(9.
PMID: 37760958
PMC: 10525947.
DOI: 10.3390/biomedicines11092517.
The role of macrophages polarization in sepsis-induced acute lung injury.
Wang Z, Wang Z
Front Immunol. 2023; 14:1209438.
PMID: 37691951
PMC: 10483837.
DOI: 10.3389/fimmu.2023.1209438.
Acute respiratory distress syndrome: potential of therapeutic interventions effective in treating progression from COVID-19 to treat progression from other illnesses-a systematic review.
Ragel E, Harris L, Campbell R
BMJ Open Respir Res. 2023; 10(1).
PMID: 37657844
PMC: 10476125.
DOI: 10.1136/bmjresp-2022-001525.